Organogenesis Inc.

The market for tissue-engineered skin replacements and wound modulators is expected to reach nearly $1.9bn in 2024, a faster rebound than certain other elective procedures that can be put on hold, acc

A provision in the US omnibus budget bill circumvents Medicare Part B reimbursement policy by reinstating "pass-through" payments in certain narrowly drawn circumstances. The bill is a disappointment

Device Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It

The seasons might be changing but the downward trend in M&A activity continued into March, with Medtech Insight 's M&A deal tracker recording nine deals only for the month. The March total was down f